Title : The bortezomib/proteasome inhibitor PS-341 and triterpenoid CDDO-Im induce synergistic anti-multiple myeloma (MM) activity and overcome bortezomib resistance.

Pub. Date : 2004 Apr 15

PMID : 15070698






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Low doses of CDDO-Im and bortezomib overcome the cytoprotective effects of antiapoptotic proteins Bcl2 and heat shock protein-27 (Hsp27) as well as nuclear factor-kappa B (NF-kappaB)-mediated growth/survival and drug resistance. Bortezomib nuclear factor kappa B subunit 1 Homo sapiens
2 Low doses of CDDO-Im and bortezomib overcome the cytoprotective effects of antiapoptotic proteins Bcl2 and heat shock protein-27 (Hsp27) as well as nuclear factor-kappa B (NF-kappaB)-mediated growth/survival and drug resistance. Bortezomib nuclear factor kappa B subunit 1 Homo sapiens